—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Corcept Therapeutics Incorporated (CORT) — Technical state

As of 2026-11-02 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 54 out of 100 (momentum 57 · quality 49 · valuation 26), as of 2026-11-03.
  • Signal: Pullback inside an uptrend stack — Trades -27.6% vs the 50-day and +7.3% vs the 200-day average, 36.3% below the 52-week high and +180.7% off the 52-week low. Computed from daily closes. (as of 2026-11-02)
  • Trend: Corcept Therapeutics Incorporated trades 27.6% below its 50-day and 7.3% above its 200-day moving average. (as of 2026-11-02)

Corcept develops drugs that block cortisol receptors, treating disorders where the body produces too much of the hormone. Its approved medicine, Korlym, treats hyperglycaemia linked to Cushing's syndrome, and it is testing further cortisol modulators, including relacorilant and miricorilant, for other endocrine and neurologic conditions.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the CORT overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Pullback inside an uptrend stack

Trades -27.6% vs the 50-day and +7.3% vs the 200-day average, 36.3% below the 52-week high and +180.7% off the 52-week low. Computed from daily closes.

Ranked #7 on today’s Directional Flow — on a pullback list (scan of 2026-11-02).

The moving-average stack

Continue: the CORT chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-11-02

Quick answers

What is the current Closelooknet signal on CORT?

Pullback inside an uptrend stack — Trades -27.6% vs the 50-day and +7.3% vs the 200-day average, 36.3% below the 52-week high and +180.7% off the 52-week low. Computed from daily closes. As of 2026-11-02; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is CORT above its 50-day and 200-day moving averages?

As of 2026-11-02, Corcept Therapeutics Incorporated trades -27.6% below its 50-day and +7.3% above its 200-day average, with the 20-day -23.5% away.

How far is CORT from its 52-week high?

36.3% below the 52-week high and 180.7% above the 52-week low, as of 2026-11-02.

Mentioned on Closelooknet

Where CORT appears in the diary — 1 piece, newest first. Every link is our own writing.

Dailies

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.